John G. Cumming

1.2k citations

30 papers · 881 indexed · h-index 17

Organic Chemistry top 5%
Molecular Biology
Computational Theory and Mathematics top 2%
Biotechnology top 5%
Pharmacology

Co-authors: Ian Paterson Richard A. Ward A. M. Davis Markus Haeberlein Sorel Mureşan Hongming Chen Julian D. Smith Kap‐Sun Yeung
Topics: Synthetic Organic Chemistry Methods (9 papers)Computational Drug Discovery Methods (7 papers)Traditional and Medicinal Uses of Annonaceae (7 papers)
Cited by: Organic Chemistry Computational Theory and Mathematics Biotechnology
Journals: Journal of the American Chemical Society Nature Reviews Drug Discovery Journal of Medicinal Chemistry
Partner nations: United Kingdom Sweden Switzerland

In The Last Decade

John G. Cumming

29 papers receiving 846 citations

Peers

Countries citing papers authored by John G. Cumming

Since Specialization

Citations

This map shows the geographic impact of John G. Cumming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John G. Cumming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John G. Cumming more than expected).

Fields of papers citing papers by John G. Cumming

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John G. Cumming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John G. Cumming. The network helps show where John G. Cumming may publish in the future.

Co-authorship network of co-authors of John G. Cumming

This figure shows the co-authorship network connecting the top 25 collaborators of John G. Cumming. A scholar is included among the top collaborators of John G. Cumming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John G. Cumming. John G. Cumming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and Characterization of MAPK-activated Protein Kinase-2 Prevention of Activation Inhibitors 2014 ·Journal of Medicinal Chemistry ·John G. Cumming,J.E. Debreczeni,Fredrik Edfeldt,Emma Evertsson,Martin Harrison,Geoffrey A. Holdgate,Michael J. James,Scott G. Lamont,Keith T. Oldham,Jane E. Sullivan,Stuart L. Wells	7
2	Potential Strategies for Increasing Drug-Discovery Productivity 2014 ·Future Medicinal Chemistry ·John G. Cumming,M. Raymond V. Finlay,Fabrizio Giordanetto,(unknown),Troy Lister,Hitesh J. Sanganee,Michael J. Waring	16
3	Chemical predictive modelling to improve compound quality 2013 ·Nature Reviews Drug Discovery ·John G. Cumming,A. M. Davis,Sorel Mureşan,Markus Haeberlein,Hongming Chen	213
4	Better compounds faster: the development and exploitation of a desktop predictive chemistry toolkit 2012 ·Drug Discovery Today ·John G. Cumming,Jon Winter,Andrew R. Poirrette	6
5	The design and synthesis of novel, potent and orally bioavailable N-aryl piperazine-1-carboxamide CCR2 antagonists with very high hERG selectivity 2012 ·Bioorganic & Medicinal Chemistry Letters ·John G. Cumming,Justin Bower,David Waterson,(unknown),(unknown),Paul Turner,(unknown),Andrew D. Campbell,Julian A. Hudson,Michael J. James,Jon Winter,Christine Wood	16
6	Balancing hERG affinity and absorption in the discovery of AZD5672, an orally active CCR5 antagonist for the treatment of rheumatoid arthritis 2012 ·Bioorganic & Medicinal Chemistry Letters ·John G. Cumming,Howard Tucker,J.W. Oldfield,(unknown),(unknown),(unknown),Martin Wild,Dearg S. Brown,Stuart L. Wells,John S. Shaw	21
7	The discovery of N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide (AZD6703), a clinical p38α MAP kinase inhibitor for the treatment of inflammatory diseases 2012 ·Bioorganic & Medicinal Chemistry Letters ·Dearg S. Brown,John G. Cumming,Paul A. Bethel,(unknown),S. Gerhardt,(unknown),Richard A. Pauptit,Kurt G. Pike,(unknown),(unknown),Steve Swallow,(unknown)	9
8	Automated QSAR with a Hierarchy of Global and Local Models 2011 ·Molecular Informatics ·David Wood,David Buttar,John G. Cumming,A. M. Davis,Ulf Norinder,(unknown)	32
9	The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis 2011 ·Bioorganic & Medicinal Chemistry Letters ·Chris De Savi,Andrew R. Pape,John G. Cumming,Attilla Ting,Peter D. Smith,Jeremy N. Burrows,(unknown),(unknown),Scott G. Lamont,(unknown),Calum Cook,Peter R. Moore,(unknown),S. Gerhardt	18
10	Orally active achiral N-hydroxyformamide inhibitors of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) for the treatment of osteoarthritis 2011 ·Bioorganic & Medicinal Chemistry Letters ·Chris De Savi,Andrew R. Pape,(unknown),(unknown),(unknown),John G. Cumming,Attilla Ting,Scott G. Lamont,Peter D. Smith,(unknown),Ken Page,Peter R. Moore	13
11	Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides 2006 ·Bioorganic & Medicinal Chemistry Letters ·John G. Cumming,S Brown,Anne Cooper,(unknown),(unknown),Ken Grime,J.W. Oldfield,John S. Shaw,(unknown),Howard Tucker,David Whittaker	15
12	Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides 2005 ·Bioorganic & Medicinal Chemistry Letters ·John G. Cumming,Anne Cooper,Ken Grime,(unknown),(unknown),J.W. Oldfield,John S. Shaw,Howard Tucker,Jon Winter,David Whittaker	21
13	Novel, potent and selective anilinoquinazoline and anilinopyrimidine inhibitors of p38 MAP kinase 2004 ·Bioorganic & Medicinal Chemistry Letters ·John G. Cumming,(unknown),Stuart Bowden,Douglas S. Campbell,(unknown),J. Breed,Philip J. Jewsbury	54
14	Modulators of the human CCR5 receptor. Part 1: Discovery and initial SAR of 1-(3,3-diphenylpropyl)-piperidinyl amides and ureas 2004 ·Bioorganic & Medicinal Chemistry Letters ·Jeremy N. Burrows,John G. Cumming,Shaun Fillery,(unknown),Julian A. Hudson,(unknown),(unknown),John S. Shaw	38
15	(S)-2-(Dibenzylamino)-3-phenylpropanal as a chiral auxiliary: a new strategy for the asymmetric synthesis of 2-substituted alcohols 1998 ·Tetrahedron Asymmetry ·Jonathan Clayden,Catherine McCarthy,John G. Cumming	15
16	Studies in marine macrolide synthesis: Boron and silicon-mediated coupling strategies for Swinholide A 1994 ·Tetrahedron Letters ·Ian Paterson,John G. Cumming,Julian D. Smith,Richard A. Ward	43
17	Total Synthesis of Swinholide A and Hemiswinholide A 1994 ·Journal of the American Chemical Society ·Ian Paterson,Kap‐Sun Yeung,Richard A. Ward,John G. Cumming,Julian D. Smith	55
18	Total Synthesis of (-)-Preswinholide A 1994 ·Journal of the American Chemical Society ·Ian Paterson,Julian D. Smith,Richard A. Ward,John G. Cumming	29
19	Towards the synthesis of swinholide A and scytophycin C. A highly stereocontrolled synthesis of (−)-pre-swinholide A 1994 ·Tetrahedron Letters ·Ian Paterson,John G. Cumming,Julian D. Smith,Richard A. Ward,Kap‐Sun Yeung	25
20	A stereocontrolled synthesis of a C19-C32 / C17-C30 Segment for swinholide A and misakinolide A, Cytotoxic dimeric macrolides from theonella swinhoei. 1992 ·Tetrahedron Letters ·Ian Paterson,John G. Cumming	26

About John G. Cumming

John G. Cumming is a scholar working on Biochemistry, Organic Chemistry and Computational Theory and Mathematics, having authored 30 papers that have together received 881 indexed citations. Recurring topics across this work include Synthetic Organic Chemistry Methods (9 papers), Computational Drug Discovery Methods (7 papers) and Traditional and Medicinal Uses of Annonaceae (7 papers). The work is most often cited by research in Organic Chemistry (500 citations), Computational Theory and Mathematics (222 citations) and Biotechnology (114 citations). John G. Cumming has collaborated with scholars based in United Kingdom, Sweden and Switzerland. Frequent co-authors include Ian Paterson, Richard A. Ward, A. M. Davis, Markus Haeberlein, Sorel Mureşan, Hongming Chen, Julian D. Smith, Kap‐Sun Yeung, Catherine McCarthy and Jonathan Clayden. Their work appears in journals such as Journal of the American Chemical Society, Nature Reviews Drug Discovery and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact